Dr Sanjeev Chaudhry




Dr. Sanjeev K Chaudhry is presently Chief Executive Officer of SRL Ranbaxy Limited and Chairman of CSC Nutrigenomics Pte Limited, Singapore. He also serves on the Board of Directors of several companies in India and abroad.

He was the South Asia head of DuPont Solae until June 2006, a position he held for eleven years.

Dr Chaudhry has lived and worked in India, Malaysia, Singapore, UK and USA.

In 1989, at age of 30, Dr Chaudhry was the youngest professional CEO of a Public Sector Company in India. He earned accolades for turning around the ailing state owned Modern Food Industries. The plan for privatization of India’s first state owned enterprise was presented to the Planning Commission of India by Dr Chaudhry and set in motion the process of divestment of state owned companies in the country.

Prior to that (1985-88) he was the head of corporate planning at RJR Nabisco/Britannia and following that President & CEO (1990-95) of NatOleo ( a Johor Corp company). NatOleo is world’s largest producer of fatty acids and glycerin and was set up as a green field project by Dr Chaudhry.

Dr Chaudhry is a visiting faculty to several leading management institutes and universities around the world. He writes guest columns for magazines and has authored three books on value education and management.

He has a Ph.D in Business Administration from Columbia University, United States and holds a university record for Masters in Economics at Punjab University, Chandigarh.

Mr. Atul Gupta
President – Margin Funding & Arbitrage Religare Finvest Limited



Mr Atul Gupta carries the overall responsibility for maintenance of relationship with the corporate clients and high net worth individuals (HNI) and provides strategic directions to the business.

Atul has over 13 year of experience in the financial services industry. Prior to joining Religare, he was acting as Manager, Commercial at Pisces Industries Limited and held several key positions from 1994 to 1999.

Atul is a commerce graduate from the University of Delhi and is also a member of the Institute of Chartered Accountant of India.

Under his leadership, the Company has achieved overall progress in terms of turnover and profitability, and established itself as a leader in the financial market.

Dr. Amit Varma
President – Healthcare Religare Enterprises Limited

Dr Amit Varma currently operates as President Health Care, Religare Enterprises and Director, Critical Care Medicine, Fortis Escorts group of Hospitals, India. Having completed his MBBS and MD from University of Delhi, Dr Varma further completed his residency from the State University of New York. Thereafter he went on to pursue fellowships in critical care at the University of Pittsburgh Medical Center, and sub specialized in cardiac critical care at the Cleveland Clinic. Alongside this, he also attended courses for an Executive MBA at the University of Chicago.

After almost a decade in USA, Dr Varma began his professional journey in India at the Manipal Heart Foundation in Bangalore. He subsequently moved on to the Narayan Hrudayalaya Hospital as the consultant- in-charge of Critical Care. Early in 2003, Dr Varma joined Fortis Healthcare, where he has and continues to perform multiple administrative and clinical roles. He currently runs the integrated critical care services for Fortis Healthcare ICU network, which today comprises of a strong three-Hundred beds and helps in ormulation of Medical Strategy.

At Religare from 2009, Dr Varma is actively engaged in all healthcare initiatives of the company, playing an advisory and steering role, overlooking and further initiating all healthcare related businesses, providing medical expertise, insight and credibility in all healthcare related verticals such as Health Insurance venture, Healthcare IT, Super Religare Labs and Religare Wellness. He also sits on the Board and Investment committee of the 125$ million Milestone Religare Private Equity fund which is investing domestically in the healthcare and education fields.